• GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race

    1 month ago - By Fierce Biotech

    GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race ntaylor
    Mon, 06/14/2021 - 04:56
    Read more ...